Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Using galectin-3 to reduce heart failure rehospitalization.

Xue Y, Maisel A, Peacock WF.

Future Cardiol. 2014 Mar;10(2):221-7. doi: 10.2217/fca.14.9.

PMID:
24762249
2.

[Impact of galectin 3 as myofibrosis marker in clinical cardiology].

Málek F.

Vnitr Lek. 2014 Apr;60(4):327-30. Review. Czech.

PMID:
24985993
3.

Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials.

Meijers WC, Januzzi JL, deFilippi C, Adourian AS, Shah SJ, van Veldhuisen DJ, de Boer RA.

Am Heart J. 2014 Jun;167(6):853-60.e4. doi: 10.1016/j.ahj.2014.02.011. Epub 2014 Mar 5.

4.

Galectin-3: a new biomarker for the diagnosis, analysis and prognosis of acute and chronic heart failure.

Hrynchyshyn N, Jourdain P, Desnos M, Diebold B, Funck F.

Arch Cardiovasc Dis. 2013 Oct;106(10):541-6. doi: 10.1016/j.acvd.2013.06.054. Epub 2013 Oct 3.

5.

Personalizing biomarker strategies in heart failure with galectin-3.

Sherwi N, Merali S, Wong K.

Future Cardiol. 2012 Nov;8(6):885-94. doi: 10.2217/fca.12.65. Review.

PMID:
23176690
6.

Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study.

Gaggin HK, Truong QA, Rehman SU, Mohammed AA, Bhardwaj A, Parks KA, Sullivan DA, Chen-Tournoux A, Moore SA, Richards AM, Troughton RW, Lainchbury JG, Weiner RB, Baggish AL, Semigran MJ, Januzzi JL Jr.

Congest Heart Fail. 2013 May-Jun;19(3):135-42. doi: 10.1111/chf.12016. Epub 2012 Dec 28.

7.

Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.

Tuñón J, Blanco-Colio L, Cristóbal C, Tarín N, Higueras J, Huelmos A, Alonso J, Egido J, Asensio D, Lorenzo Ó, Mahíllo-Fernández I, Rodríguez-Artalejo F, Farré J, Martín-Ventura JL, López-Bescós L.

Am J Cardiol. 2014 Feb 1;113(3):434-40. doi: 10.1016/j.amjcard.2013.10.012. Epub 2013 Nov 7.

PMID:
24295549
8.

Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.

van der Velde AR, Gullestad L, Ueland T, Aukrust P, Guo Y, Adourian A, Muntendam P, van Veldhuisen DJ, de Boer RA.

Circ Heart Fail. 2013 Mar;6(2):219-26. doi: 10.1161/CIRCHEARTFAILURE.112.000129. Epub 2013 Feb 8.

9.

Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial.

Lopez-Andrès N, Rossignol P, Iraqi W, Fay R, Nuée J, Ghio S, Cleland JG, Zannad F, Lacolley P.

Eur J Heart Fail. 2012 Jan;14(1):74-81. doi: 10.1093/eurjhf/hfr151. Epub 2011 Nov 16.

10.

Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.

Green SM, Green JA, Januzzi JL Jr.

Am J Ther. 2009 Mar-Apr;16(2):171-7. doi: 10.1097/MJT.0b013e318172797f. Review.

PMID:
19300043
11.

Galectin-3 in cardiac remodeling and heart failure.

de Boer RA, Yu L, van Veldhuisen DJ.

Curr Heart Fail Rep. 2010 Mar;7(1):1-8. doi: 10.1007/s11897-010-0004-x. Review. Erratum in: Curr Heart Fail Rep. 2012 Sep;9(3):163.

12.

The fibrosis marker galectin-3 and outcome in the general population.

de Boer RA, van Veldhuisen DJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Hillege HL, Bakker SJ, van der Harst P.

J Intern Med. 2012 Jul;272(1):55-64. doi: 10.1111/j.1365-2796.2011.02476.x. Epub 2011 Nov 18.

13.

[Galectin 3--a new biomarker for diagnostics and outcome of chronic heart failure].

Lakomkin SV, Skvortsov AA, Goriunova TV, Masenko VP, Tereshchenko SN.

Kardiologiia. 2012;52(3):45-52. Review. Russian.

PMID:
22839443
14.

Usefulness of combining galectin-3 and BIVA assessments in predicting short- and long-term events in patients admitted for acute heart failure.

De Berardinis B, Magrini L, Zampini G, Zancla B, Salerno G, Cardelli P, Di Stasio E, Gaggin HK, Belcher A, Parry BA, Nagurney JT, Januzzi JL Jr, Di Somma S.

Biomed Res Int. 2014;2014:983098. doi: 10.1155/2014/983098. Epub 2014 Jun 30.

15.

Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?

Srivatsan V, George M, Shanmugam E.

Eur J Prev Cardiol. 2015 Sep;22(9):1096-110. doi: 10.1177/2047487314552797. Epub 2014 Sep 29. Review.

PMID:
25268020
16.

Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.

Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA.

Am J Cardiol. 2009 Jun 15;103(12):1753-9. doi: 10.1016/j.amjcard.2009.02.029.

PMID:
19539088
17.

Galectin 3 complements BNP in risk stratification in acute heart failure.

Fermann GJ, Lindsell CJ, Storrow AB, Hart K, Sperling M, Roll S, Weintraub NL, Miller KF, Maron DJ, Naftilan AJ, McPherson JA, Sawyer DB, Christenson R, Collins SP.

Biomarkers. 2012 Dec;17(8):706-13. doi: 10.3109/1354750X.2012.719037. Epub 2012 Sep 24.

18.

Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.

Michtalik HJ, Yeh HC, Campbell CY, Haq N, Park H, Clarke W, Brotman DJ.

Am J Cardiol. 2011 Apr 15;107(8):1191-5. doi: 10.1016/j.amjcard.2010.12.018. Epub 2011 Feb 4.

PMID:
21296322
19.

Review of the prognostic value of galectin-3 in heart failure focusing on clinical utility of repeated testing.

Carrasco-Sánchez FJ, Páez-Rubio MI.

Mol Diagn Ther. 2014 Dec;18(6):599-604. doi: 10.1007/s40291-014-0113-4. Review.

PMID:
24989720
20.

Galectin-3: a novel mediator of heart failure development and progression.

de Boer RA, Voors AA, Muntendam P, van Gilst WH, van Veldhuisen DJ.

Eur J Heart Fail. 2009 Sep;11(9):811-7. doi: 10.1093/eurjhf/hfp097. Epub 2009 Jul 31. Review.

Supplemental Content

Support Center